DNA repair in cancer therapy : molecular targets and clinical applications /

Saved in:
Bibliographic Details
Edition:Second edition.
Imprint:London, United Kingdom : Academic Press is an imprint of Elsevier, 2016.
Description:1 online resource (xix, 444 pages) : color illustrations
Language:English
Subject:Cancer -- Gene therapy.
DNA repair.
Cancer -- Gene therapy.
DNA repair.
DNA Repair.
Neoplasms -- therapy.
Electronic books.
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11264331
Hidden Bibliographic Details
Other authors / contributors:Kelley, Mark Richard, 1957- editor.
Fishel, Melissa L., editor.
ISBN:9780128035993
0128035994
9780128035825
012803582X
Notes:Includes bibliographical references and index.
Print version record.
Summary:DNA Repair and Cancer Therapy: Molecular Targets and Clinical Applications, Second Edition provides a comprehensive and timely reference that focuses on the translational and clinical use of DNA repair as a target area for the development of diagnostic biomarkers and the enhancement of cancer treatment. Experts on DNA repair proteins from all areas of cancer biology research take readers from bench research to new therapeutic approaches. This book provides a detailed discussion of combination therapies, in other words, how the inhibition of repair pathways can be coupled with chemotherapy, radiation, or DNA damaging drugs. Newer areas in this edition include the role of DNA repair in chemotherapy induced peripheral neuropathy, radiation DNA damage, Fanconi anemia cross-link repair, translesion DNA polymerases, BRCA1-BRCA2 pathway for HR and synthetic lethality, and mechanisms of resistance to clinical PARP inhibitors.
Other form:Print version: DNA repair in cancer therapy. Second edition. Amsterdam : Elsevier : Academic Press, 2016 012803582X
LEADER 03547cam a2200505Ii 4500
001 11264331
005 20180526100211.8
006 m o d
007 cr cnu---unuuu
008 160708s2016 enka ob 001 0 eng d
010 |a  2016937806 
019 |a 957615332 
020 |a 9780128035993 
020 |a 0128035994 
020 |z 9780128035825  |q (print) 
020 |z 012803582X  |q (print) 
035 |a (OCoLC)953267539  |z (OCoLC)957615332 
040 |a OPELS  |b eng  |e rda  |e pn  |c OPELS  |d UIU  |d OCLCF  |d YDX  |d PFM  |d TMC  |d VTM  |d UIU  |d CHVBK  |d OCLCO  |d OCLCA  |d OCLCO  |d OCLCQ  |d Z5A  |d OCLCO  |d MERER  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d LEATE  |d U3W  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d BUF  |d OCLCO  |d OCLCQ 
049 |a MAIN 
050 4 |a RC270.8  |b .D53 2016e 
060 4 |a QZ 267  |b D629 2016e 
245 0 0 |a DNA repair in cancer therapy :  |b molecular targets and clinical applications /  |c edited by Mark R. Kelley, Melissa L. Fishel. 
250 |a Second edition. 
264 1 |a London, United Kingdom :  |b Academic Press is an imprint of Elsevier,  |c 2016. 
300 |a 1 online resource (xix, 444 pages) :  |b color illustrations 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a computer  |b c  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/c 
338 |a online resource  |b cr  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/cr 
504 |a Includes bibliographical references and index. 
520 |a DNA Repair and Cancer Therapy: Molecular Targets and Clinical Applications, Second Edition provides a comprehensive and timely reference that focuses on the translational and clinical use of DNA repair as a target area for the development of diagnostic biomarkers and the enhancement of cancer treatment. Experts on DNA repair proteins from all areas of cancer biology research take readers from bench research to new therapeutic approaches. This book provides a detailed discussion of combination therapies, in other words, how the inhibition of repair pathways can be coupled with chemotherapy, radiation, or DNA damaging drugs. Newer areas in this edition include the role of DNA repair in chemotherapy induced peripheral neuropathy, radiation DNA damage, Fanconi anemia cross-link repair, translesion DNA polymerases, BRCA1-BRCA2 pathway for HR and synthetic lethality, and mechanisms of resistance to clinical PARP inhibitors. 
588 0 |a Print version record. 
650 0 |a Cancer  |x Gene therapy.  |0 http://id.loc.gov/authorities/subjects/sh92005201 
650 0 |a DNA repair.  |0 http://id.loc.gov/authorities/subjects/sh85037009 
650 7 |a Cancer  |x Gene therapy.  |2 fast  |0 http://id.worldcat.org/fast/fst00845367 
650 7 |a DNA repair.  |2 fast  |0 http://id.worldcat.org/fast/fst00886599 
650 1 2 |a DNA Repair.  |0 http://id.nlm.nih.gov/mesh/D004260 
650 1 2 |a Neoplasms  |x therapy.  |0 http://id.nlm.nih.gov/mesh/D009369Q000628 
655 4 |a Electronic books. 
700 1 |a Kelley, Mark Richard,  |d 1957-  |e editor.  |0 http://id.loc.gov/authorities/names/n89647219 
700 1 |a Fishel, Melissa L.,  |e editor.  |0 http://id.loc.gov/authorities/names/n2016188772 
776 0 8 |i Print version:  |t DNA repair in cancer therapy.  |b Second edition.  |d Amsterdam : Elsevier : Academic Press, 2016  |z 012803582X  |w (OCoLC)946605525 
903 |a HeVa 
929 |a oclccm 
999 f f |i 0e053709-7222-5f37-b821-a179e144170e  |s 6c499c6d-a8e4-56e1-9a0f-597e39001cbd 
928 |t Library of Congress classification  |a RC270.8 .D53 2016e  |l Online  |c UC-FullText  |u https://www.sciencedirect.com/science/book/9780128035825  |z Elsevier  |g ebooks  |i 10979216